<ul><li>Production plant: 6,000 m²</li><li>Technical development labs: 120 m²</li><li>Analytical labs: 340 m²</li><li>Warehouse &amp; distribution: 1,450 m²</li><li>Offices: 2,400 m²</li><li>FTE: 172</li><li>Shifts: 3/5days (15 weekly shifts)</li></ul>

<ul><li>Production of soft gelatin capsules</li><li>OEB 1-5, incl. narcotics</li><li>Quality services</li></ul>

<ul><li>Analytical services</li><li>Formulation and process development</li><li>Product transfer</li><li>Integrated project management</li><li>Lifecycle management</li><li>Quality by design</li><li>Clinical trial material</li></ul>

Blister packaging incl. serialization and aggregation (implemented Q3/2023)

<ul><li>Manufacturing licenses<ul><li>Swissmedic (GMP, controlled substances, GDP)</li></ul></li><li>Non EU-GMP certificates<ul><li>US FDA</li><li>Chinese FDA</li><li>Iraq</li><li>Korean MFDS</li><li>Russian MoH</li><li>SFDA (Saudi Arabia) </li><li>TGA (Australia) </li><li>Turkish MoH</li></ul></li><li>Food standards<ul><li>BRC</li></ul></li><li>Kosher</li><li>Halal</li><li>ISO certificate: ISO 14001</li><li><a href="https://www.aenova-group.com/content/company/sites/SWISS_CAPS_Aenova_HSE_UMHB_Umweltpolitik.pdf">SWISS CAPS Aenova HSE UMHB Environmental Policy</a> </li></ul>

<ul><li>Rx incl. high potent APIs</li><li>Generics</li><li>Narcotics</li><li>OTC</li><li>Food supplements</li><li>COSM</li></ul>

Technologies

Manufacturing
<ul><li>Equipment formulation <ul><li>2 preparation vessels for gelatin</li><li>7 formulation vessels for suspensions (up to 2.000 kg; including Becomix and Fryma technology)</li><li>SMEPAC qualified API dispensing and formulation equipment for high potent up to OEB 5</li></ul></li><li>Equipment encapsulation<ul><li>7 encapsulation machines for soft gelatin capsule production</li><li>1 encapsulation machine for very small scale early phase development trials</li><li>Capsule drying in tumblers or trays at narrow controlled relative humidity ranges</li></ul></li><li>Laser and offset printing<ul><li>1 laser printing line</li><li>1 offset (ink) printing line</li></ul></li><li>Sorting and bulk packaging<ul><li>4 sorting and bulk packaging lines</li></ul></li><li>Blister packaging<ul><li>1 fully integrated line including serialization and aggregation</li><li>special capability tropical blisters and large (e.g. vaginal) capsules</li></ul></li></ul>
Quality Control
<ul><li>10 HPLC systems</li><li>4 GC systems</li><li>2 Dissolution test systems</li><li>3 Titration systems</li><li>1 Particle size analyzer</li><li>1 NIR spectrophotometer</li><li>1 FTIR spectrophotometer</li><li>2 UV/Vis spectrophotometers</li></ul>

Products

<ul><li>Analgesics </li><li>Anti-acne preparations </li><li>Antianemic preparations</li><li>Antiemetics and antinauseants </li><li>Antiepileptics</li><li>Anti-inflammatory and antirheumatic products</li><li>Bile and liver therapy</li><li>Calcium channel blockers</li><li>Cardiac therapy </li><li>Cough and cold preparations</li><li>Digestives, including enzymes</li><li>Drugs for functional gastrointestinal disorders</li><li>Drugs for obstructive airway diseases</li><li>General nutrients</li><li>Gynecological antiinfectives and antiseptics</li><li>Immunostimulants</li><li>Immunosuppressants</li><li>Laxatives</li><li>Lipid modifying agents</li><li>Mineral supplements</li><li>Other alimentary tract and metabolism products</li><li>Other dermatological preparations</li><li>Other drugs for disorders of the musculo-skeletal system </li><li>Other hematological agents</li><li>Other lipid modifying agents</li><li>Other nervous system drugs</li><li>Psychoanaleptics</li><li>Psycholeptics</li><li>Sex hormones and modulators of the genital system</li><li>Tonics</li><li>Urologicals</li><li>Vasoprotectives</li><li>Vitamins</li><li>Vitamins, antioxidants</li></ul>

Kirchberg

The Aenova site in Kirchberg has special expertise in the development, production and analytical testing of pharmaceutical soft gelatin capsules, including high potent APIs.

The Aenova site in Kirchberg has special expertise in the development, production and packaging of pharmaceutical soft gelatine...

Kirchberg - Aenova Group

Data Protection Principles

employees

certifications & approvals

square meter

Capsule Fill Preparation Kirchberg Aenova

High-potent dispensing isolator Kirchberg Aenova

Capsule fill preparation Kirchberg Aenova

Encapsulation Kirchberg Aenova

Dryers Kirchberg Aenova

Quality control Kirchberg Aenova

Capsule sorting Kirchberg Aenova

Aerial picture Kirchberg Aenova

Aenova Site Kirchberg Pharmaceutical Softgel Capsules

Facts

<figure><div class="testimonial-person">
<div>Sandra Matthießen 
Manager Purchasing</div>
<img class="testimonial-image" src="https://next.aenova-group.com/content/manufacturing/_crop500/Paul-Boskamp-Sandra-Matthie%C3%9Fen.jpg" alt="Sandra Matthießen" /> 

</div></figure>
As a traditional German family owned company, Pohl Boskamp has a strong reputation with the medical and pharmacies community. This is the result of years lasting research for new medicines and of optimization of already existing drugs. Our products have distinguished themselves for a fast effect coupled with an excellent patient tolerance. To achieve these results our collaboration with Swiss Caps AG is key. We are looking back at over 20 years of intense and fruitful collaboration. Started in 1999 as a pure supplier agreement it has developed in a mutually beneficial cooperation: we do appreciate Swiss Caps AG’s reliability high quality standards and excellent customer support. They supply us with one of our main products for respiratory indications, for which the softgel formulation is integral part of our product. As we move forward into new fields and explore new markets, we are sure that Swiss Caps AG will be a very important part for our success story.

Reference Pohl Boskamp

<figure><div class="testimonial-person"> <div>Herr Metzler General Manager Manufacturing Network Development</div> <img class="testimonial-image" src="https://next.aenova-group.com/content/manufacturing/_crop500/Michael-Metzler-douglas_1.jpg" alt="" /> </div></figure>
 
At Douglas Pharmaceuticals we do have a reputation for high manufacturing standards, quality products and outstanding client service. Based in New Zealand we always look for long lasting partnerships in other global regions that can maintain our high standards. That is the reason why Swiss Caps AG was a logical choice for us. With their OTD close to 100 % and the complaint rate below 1%, Swiss Caps AG allows us to concentrate on our growth plans.The cooperation commenced in 1994 with the development of a generic product. Swiss Caps AG’s specific technology knowledge was key to the fast and efficient launch of the product in 1998 for the European market. Since then the business has been growing constantly and the product is now one of our main financial drivers. One of the biggest milestones was the launch in the Eu and US, with other markets following. A further milestone in our collaboration was our Lean Initiative in 2017 to identify and implement further operational improvements into our cooperation. In 2020 we kicked-off an intercompany Engagement Plan with the focus on continuous improvement and jointly developing new business opportunities.We have always considered Swiss Caps AG as a partner more than a supplier. Their proficiency coupled with the willingness to go the extra mile and their deep knowledge of soft gelatin capsule technology is the reason we consider Swiss Caps AG as a reliable and trustworthy partner. We look forward to expanding our future collaborations with them.

Reference Douglas

Location Kirchberg, Switzerland
Competence Center Soft gelatin capsules

The Aenova site in Kirchberg has special expertise in the development, production and analytical testing of pharmaceutical soft gelatin capsules, including high potent APIs. In our competence center for pharmaceutical soft capsules, we apply decades of know-how and state-of-the-art infrastructure to deliver flawless quality to our customers worldwide. With our innate Swiss reliability, we always deliver our products on time. Hand in hand, our experienced team works with passion to find innovative solutions for demanding customer needs. Our high service standards are the driving force for long-term, successful partnerships with our customers.

New Aenova White Paper: Softgel Capsules. A solution for poorly soluble and low bioavailability APIs

28/06/2024 - New Aenova White Paper: Softgel Capsules. A solution for poorly soluble and low bioavailability APIs

Starnberg, 28/06/2024

Low aqueous drug solubility in pharmaceutical development is a recurring issue. The softgel capsule offers many possibilities in the development of new drugs, especially when it comes to solubility and bioavailability enhancement. In the current white paper, experts from Aenova explain the challenges of softgel capsules in development and commercial production, particularly considering the complexity of softgel production technology, as well as the suitability of the softgel capsule as an appropriate dosage form for certain areas of application.
Explore the transformative potential of softgel capsule technology with the new Aenova white paper. This white paper delves into the intricacies of developing and producing softgel capsules, highlighting the advantages they provide in drug formulation, including improved stability, patient-friendly administration, and precise dosing. With insights from Aenova’s decades of expertise, learn how an experienced CDMO can be a valuable partner in unlocking alternative forms of drug delivery and driving the success of your pharmaceutical products.
Get in touch with our <a href="mailto:contact-sales@aenova-group.com?subject=New Aenova white paper Softgel Capsules" target="_blank">sales team</a> right away.
Learn more in our <a href="https://www.aenova-group.com/content/Aenova_Whitepaper_Pharmaceutical_Softgel_Capsules.pdf">white paper "Softgel Capsules. A solution for poorly soluble and low bioavailability APIs".</a>

Aenova supports Heimstätten Wil foundation with a donation of 2,000.00 euros

04/04/2024 - Aenova supports Heimstätten Wil foundation with a donation of 2,000.00 euros

Kirchberg, 04/04/2024

Aenova presented the Heimstätten Wil Foundation with a cheque for 2,000.00 euros on April 3, 2024. The idea for the donation campaign was born at the Aenova Corporate Sales Meeting, which took place at the Aenova site in Kirchberg (SG), Switzerland, in February. The company already has a long-standing partnership with the Heimstätten Wil foundation. The Heimstätten Wil Foundation offers living and working spaces for around 400 adults with disabilities. The services are geared towards their individual needs and requirements. External jobs are also offered in cooperation with companies in the primary labor market. Around 160 specialists, apprentices and interns work at the foundation. The Aenova site in Kirchberg has been working with the Heimstätten Wil foundation since the pandemic. Back then, the pharmaceutical company commissioned the foundation to assemble Christmas hampers for its employees. Aenova develops, produces and packages soft gelatine capsules in Kirchberg for the pharmaceutical and healthcare industry, helping patients all over the world to lead healthier lives. More than two billion capsules leave the factory every year and are sold in over 100 countries worldwide, including Europe, the USA and China. The site also fills softgel capsules with highly effective active ingredients in extremely low dosages, where the proverbial Swiss precision is required. Around 170 employees contribute to the success of the company in Kirchberg. "I am very pleased with the decision to donate to an organization in our immediate neighbourhood. We would like to make a contribution to the valuable work of the Heimstätten Wil Foundation," explains Dr. Christian Luftensteiner, Managing Director at the Aenova site in Kirchberg. "Thank you to the Aenova Corporate Sales employees for their generous donation! Every bit of support helps us to get closer to our vision of an inclusive society," says Arlette A. Hippmann, Head of Communications, Heimstätten Wil Foundation.
<figure><img src="https://www.aenova-group.com/content/_medium/Aenova_Stiftung-Heimstaetten-Wil-Scheckuebergabe_11.JPG" data-image="561988" alt="Scheckübergabe Wil"><figcaption>Presentation of the Aenova donation check to the Heimstätten Wil Foundation. From left to right: Dr. Christian Luftensteiner, Managing Director of SWISS CAPS AG, Arlette Hippmann, Head of Communications at the Heimstätten Wil Foundation, Thomas Kleeberg, Vice President Business Management, Aenova (Photo: Daniel Müller, employee of the development workshop, Heimstätten Wil Foundation)</figcaption></figure>

National Future Day in Kirchberg SG

16/11/2023 - National Future Day at Kirchberg SG site

Kirchberg, 16/11/2023

This year's National Future Day took place in Switzerland on November 9. 12 girls and boys left the classroom and immersed themselves in the world of work at our Kirchberg SG site for a day. A change of scene that turned into a big "working day" for our young guests. The schoolchildren were given many insights into a wide variety of professions at our Kirchberg site: in the laboratory, the workshop, production, the high-bay warehouse and the offices. Under expert guidance, they were able to carry out their own color experiments in the laboratory, "cook" gelatine in the large production kitchen and process it with rubber gloves, weld little men and name tags in the workshop and climb onto a large forklift truck in the high-bay warehouse - all this and much more was offered to the children on Future Day. Around 2,500 companies, organizations, vocational schools and universities gave interested schoolchildren an insight into gender-atypical fields of work on Future Day 2023. This allows girls and boys to look at their professional future without rigid gender stereotypes.The Aenova site in Kirchberg is a competence center for the development and production of soft gelatine capsules.
<figure><img src="https://www.aenova-group.com/content/_medium/Nat_Zukunftstag_KIR_2023.jpg" data-image="560048" alt="Nationaler Zukunftstag Kirchberg 2023"><figcaption>Pupils learn about professions regardless of gender on National Future Day</figcaption></figure>

Open House at Aenova Kirchberg site

19/09/2023 - Open House at Aenova Kirchberg site

Kirchberg, 19/09/2023

Aenova Kirchberg site produces highly potent drug products for the international pharmaceutical market. As one of the major employers in the region, the Aenova site opened its doors to the public on Saturday, September 16, 2023. There were guided tours of the laboratories and production; a festive restaurant with entertainment and a children's fun event rounded off the program of events. Around 1,000 interested guests visited the open day. The Aenova site in Kirchberg (SG), Switzerland, SWISS CAPS AG, develops and produces softgelatine capsules for the pharmaceutical industry, helping patients around the world to lead healthier lives. More than two billion capsules leave the factory every year and are distributed in over 100 countries worldwide, including Europe, the USA and China. In Kirchberg, softgel capsules are also filled with highly potent active ingredients in the lowest possible dosage, where the proverbial Swiss precision is required. Currently, a high-tech tropical blister line is being commissioned for such a new product to protect the drug even in extreme climatic conditions. Aenova is also investing heavily in sustainability in Kirchberg; with solar modules on flat roofs and carports, the site aims to generate more than 400,000 kWh of solar power annually itself in the future. Around 170 employees contribute to the success of the site. At the open day on September 16, 2023, interested parties from all over the region were able to take a look at the exciting world of pharmaceutical production. Around 1,000 visitors took the opportunity to look behind the scenes of the development and production of medicines "Made in Switzerland". During various plant tours, SWISS CAPS AG employees provided information on all questions. Visitors were also treated not only to food and drink stands, but also to entertainment provided by the Altoberndorf music band and the Gähwil male voice choir. For the children, fun was organized with the Jungwacht and Blauring Kirchberg, and there was a raffle with attractive prizes. "As one of the largest employers in the region, it was a great pleasure for us to give visitors a glimpse into the highly regulated world of pharmaceutical manufacturing. It's not something that happens every day. I would like to thank all those involved and, of course, all the interested guests," explains Dr. Christian Luftensteiner, Managing Director of Aenova's Kirchberg site.
<figure><img src="https://www.aenova-group.com/content/_medium/Aenova_TOFT_Kirchberg_Labor.jpg" data-image="559361" alt="Im Labor Kirchberg beim Tag der Offenen Tür"><figcaption>In the laboratory: Experts explain the activities in the laboratory to members of the Kirchberg municipal council (Photo: Aenova)</figcaption></figure>

Sisseln

Interesting insights for school students into the pharmaceutical professional world

18/11/2022 - National Future Day at Aenova in Switzerland a complete success

Kirchberg / Sisseln, 18.11.2022

It's been a long time since there was so much going on at our manufacturing sites in Kirchberg and Sisseln, Switzerland: both sites were buzzing like a beehive, so many interested young students had registered for the National Future Day in Switzerland on November 10.And there was a lot on offer: there were experiments, welding, milling, guided tours of the laboratories, production and the high-bay warehouse. Many questions were asked and these were answered in detail and vividly, e.g. on the topics of hygiene and cleanliness in pharmaceutical production, on apprenticeships in the pharmaceutical and healthcare industry, and much more. The young people and their curiosity about what we do at Aenova, what perspectives there are in professional life and above all: how to give a change of perspective on the classic girl and boy roles in career choice were the focus of the day. At the end of the day, the unanimous feedback was: this open day was a great opportunity to look behind the scenes of one of the world's leading pharmaceutical contract manufacturers. A big thank you to all the young visitors for coming - a big thank you to all our employees who made the day an experience for young and old alike! We look forward to the next Future Day next year! 
<figure><img src="https://www.aenova-group.com/content/_medium/ZUkunftstag-CH-2022-EN.jpg" data-image="555288" alt="Nationaler Zukunftstag"><figcaption>Experiments, guided tours and lots of fun: National Future Day at the Aenova sites in Kirchberg and Sisseln</figcaption></figure>

Aenova site Kirchberg in Switzerland introduces comprehensive ISO environmental management system

29/03/2022 - Aenova Kirchberg introduces comprehensive ISO environmental management system

29.03.2022

Aenova, global leading development service provider and contract manufacturer for the pharmaceutical and healthcare industries, is expanding environmental certifications. At the end of 2021, the Aenova site in Kirchberg (SG, Switzerland) successfully passed the ISO14001:2015 certification, documenting its comprehensive environmental management.
The Aenova Group's production site for soft gelatin capsules in Kirchberg, Switzerland (Swiss Caps AG, Member of the Aenova Group) has been practicing an effective management system for many years to reduce the impact of the plant on the environment. Especially because of the plant's specialization in highly active pharmaceutical products, effective environmental management is of great importance. In order to further improve this environmental management system and to demonstrate the performance to employees, the community, the authorities and last but not least to customers, a certification according to the ISO14001:2015 standard was sought.
In an audit lasting almost a week at the end of 2021, the inspectors were able to demonstrate the complete functionality and conformity of the comprehensive environmental management system at Aenova in Kirchberg. This led to the official award of the ISO14001:2015 certificate at the end of 2021. "The production steps in the pharmaceutical industry are energy-intensive. With our environmental management system, we can now control even better that natural resources are conserved," explains Jochen Niethammer, Head of Technical Affairs and responsible for the ISO certification.
The certification underscores Aenova's efforts to continuously improve the defined environmental performance targets. For example, Aenova's Kirchberg site has now switched its electricity supply completely to "green" hydropower and plans to install a large photovoltaic system before the end of 2022. Among other things, this will supply electricity to newly installed charging stations for electric cars and thus further motivate the workforce to use e-mobility.
"The Aenova site in Kirchberg has many years of expertise in the development and production of soft gelatin capsules, especially of highly potent active pharmaceutical ingredients for sometimes vital medicines. We are aware of this responsibility to patients worldwide on a daily basis. By obtaining the ISO environmental certificate, we are also demonstrating an ongoing development of our responsibility in environmental issues," says Dr. Christian Luftensteiner, Managing Director at the Aenova site in Kirchberg. 
<figure><img src="https://www.aenova-group.com/content/navigation/_medium/Aenova_Kirchberg_ISO-Team.jpg" data-image="545552" alt="Aenova Kirchberg ISO 14001:2015 Zertifizierung"><figcaption>The certification team at Aenova's Kirchberg site proudly presents the ISO 14001:2015 certificate achieved (Photo: Aenova)</figcaption></figure>

Aenova Whitepaper "Cannabinoids: Therapeutic effects and the advantages of soft capsules as appropriate dosage form"

13/12/2021 - Aenova Whitepaper: The advantages of softgel capsules as a dosage form for cannabinoids

Kirchberg, 13/12/2021

Cannabinoids can provide great benefits for the treatment of cancer and central nervous system diseases. Softgel capsules are the preferred delivery form for cannabinoid products for many reasons. Aenova presents this in the new white paper "Cannabinoids: Therapeutic effects and the advantages of soft capsules as appropriate dosage form".
Cannabis has been in the public discussion for several years. This concerns the questions of legalization as well as the therapeutic use. Medicinally, cannabinoids are used in various fields of application, e.g. for neuropathic pain and spasticity, for loss of appetite in case of HIV as well as for nausea and vomiting under chemotherapy and for specific infantile forms of epilepsy. The new white paper from Aenova entitled "Therapeutic effects and the advantages of soft capsules as appropriate dosage form" first reviews the history of the therapeutic use of cannabinoids and presents the regulatory framework as well as the current state of the legal situation. A special case is the development of cannabinoid drugs for medical use. For synthetic or natural cannabinoids with a clear origin and defined specifications, clinical trials for well-defined indications have high chances of success. However, to date, there is no approved marketing authorisation application for cannabis to treat any disease or condition. This is due to the fact that cannabis itself has a complex and difficult to characterize composition. About 120 different cannabinoids are present in Cannabis sativa, Cannabis indica and Cannabis ruderalis. Only two of these are well characterized: Cannabidiol (CBD) and Tetrahydrocannabinol (THC). A look at the endocannabinoid system, the number of clinical trials and the current market situation for cannabinoids completes the presentation. Crucial in this context is the question of the appropriate dosage form of cannabinoids. For pharmaceutical purposes, several different ones have been considered for the formulation of cannabinoids: oral, nasal, sublingual, transcutaneous, rectal, etc. Oral administration is often preferred because of its ease of use and lower regulatory hurdles. Softgel capsules, on the other hand, are particularly well suited as the preferred form of administration because of their specific properties. The authors of the white paper, Dr. Mario Arangio and Dr. Christian Luftensteiner, are proven experts in the development and manufacture of softgel capsules at Swiss Caps AG, Member of the Aenova Group, at the Kirchberg site in Switzerland. With 4,300 employees, Aenova is one of the world's leading contract developers and manufacturers for the pharmaceutical and healthcare industries. The Swiss site is a center of excellence for the development and production of softgel capsules including highly potent APIs (OEB 5) and has over 35 years of experience in the formulation, analytical development and production of softgel capsules. The white paper (16 pages) can be requested free of charge at <a href="mailto:contact-sales@aenova-group.com">contact-sales@aenova-group.com</a>. <h5>Data protection information</h5>
For data protection reasons, we would like to point out that we consider your e-mail requesting the whitepaper at the above-mentioned e-mail address as consent to receive the whitepaper. By doing so, you also consent that Aenova Holding GmbH may contact you under the contact data stored in your request e-mail (e.g. in a signature) for promotional purposes for Aenova's own services. The provision of your consent is voluntary. You can revoke it at any time free of charge, for example by sending a new e-mail to contact-sales@aenova-group.com. Further general information on data protection can be found here <a href="https://www.aenova-group.com/en/privacy/privacy-policy">https://www.aenova-group.com/en/privacy/privacy-policy</a>

PR Aenova Probiotic softgel capsules

New probiotic softgel capsules support the health of the gut flora

25/10/2021 - New probiotic softgel capsules support the health of the gut flora

Kirchberg, 25/10/2021

The new probiotic formulations are based on a dedicated shell combined with suitable fill mass enhancers. The new capsules are easy to swallow. The capsule content can be adapted to special needs and further ingredients. Taste, colour, and size are customizable.
With its probiotic softgel capsules, the Aenova Group, a global leading contract manufacturer and developer for the pharmaceutical and healthcare industries, has developed a new product for the wellbeing of the human body at its Swiss site in Kirchberg. The new capsules, which contain living bacteria or yeasts, do combine the advantages of the soft gelatin formulation technology with the health benefits of Probiotics.
Probiotics help to restore the natural balance of bacteria in the gut when it has been disrupted by an illness or treatment. Some pathological conditions they can help with are irritable bowel syndrome, inflammatory bowel disease (IBD), infectious diarrhea (caused by viruses, bacteria, or parasites) or diarrhea caused by antibiotics.
The microorganisms, which are encapsulated under special conditions, do show activity and growth after production and storage. Therefore, viability of the contained “good” bacteria and yeasts is assured.
"Following our mission we pride ourselves on delivering innovative products and services to healthcare customers that improve and extend patients' lives”, states Dr. Christian Luftensteiner, Managing Director of Aenova’s Swiss site at Kirchberg. “In our Center of Excellence for soft capsules we apply decades of know-how and most modern infrastructure to provide impeccable quality to our customers worldwide.” Visit Aenova at the CPhI trade show in Milan, November 9 – 11, 2021, booth 2C20, hall 2.
<figure><img src="https://www.aenova-group.com/content/navigation/_medium/Probiotics_Softgels_Aenova.jpg" alt="Aenova Probiotic softgels" /><figcaption>Aenova Probiotic softgels (Photos: Aenova)</figcaption></figure>

Space project in kindergarten: Little astronauts travel into space

Kirchberg, 20/04/2021

For the children of the Zuckenriet kindergarten near Kirchberg (CH), an interesting project turned into a true fantasy journey into space. Traveling in COVID-19 times: that's as good as impossible; traveling into space: even more so. But a project of the kindergarten Zuckenriet made it possible. For quite some time now, outer space, the sun, the moon and the stars have been the subject of a project in the kindergarten. The children learned about the planets of the solar system, observed the moon at home in the evening and reported the next day how it changes from night to night. Then the idea came up to make a fantastic research trip into space. Astronaut helmets were quickly made with balloons and paste, and the little astronauts could look into space from the cut-out, silver-edged peephole of the helmets. A room lined with aluminum foil became the rocket's interior. Now all that was missing were the matching "space suits. For this, the kindergarten asked Swiss Caps AG, a member of the Aenova Group. The Aenova Group is a leading global contract manufacturer for the pharmaceutical and healthcare industries. At the Kirchberg site, soft gelatine capsules are developed and produced, such as high-dose vitamin D preparations. High standards of hygiene are set in pharmaceutical production. For this reason, employees only enter the production rooms wearing special protective suits, which have now become "space suits" in the Zuckenriet kindergarten. With this, the spaceman ambience was complete and the journey into space could begin. A great project that made learning, creativity and fun possible even in times of pandemic.
<figure style="float:left;width:876px;max-width:876px;margin-left:10px;margin-right:10px;"><img src="https://www.aenova-group.com/content/navigation/_medium/Aenova_Kleine_Astronauten_20042021_hr.jpg" alt="Kleine Astronauten im All" /><figcaption>Little astronauts in the Zuckenriet kindergarten. The "space suits" were donated by the Swiss Caps AG, Member of the Aenova Group. (Photo: privat)</figcaption></figure>

Kirchberg

The Production Plant

Manufacturing Services

Development Services

Packaging Services

Certifications & Approvals

Product Types

Address

News